Floatz logo

Ethiodized Oil

Lenvatinib

Sun Yat-sen UniversityPhase 2Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

14 Active assets in the Lenvatinib cohort.

Asset / SponsorPhaseRating
LENVATINIB
Sun Yat-sen University
Phase 2BB
Theprubicin
Sun Yat-sen University
Phase 2B
Tislelizumab
Zhejiang Cancer Hospital
Phase 2B
Pembrolizumab
National Taiwan University Hospital
Phase 2B
Regorafenib
Ju Hyun Shim
Phase 2CCC

View all 14 →

Same molecule, other indications

Ethiodized Oil is also rated in:

hepatocellular carcinomaDormant
BB
Indicative ·
70 / 100
View asset →
Colon Cancer Liver MetastasisDormant
BB
Indicative ·
66 / 100
View asset →
Neoplastic Cells, CirculatingDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →